ADAPTHEALTH CORP (AHCO) Fundamental Analysis & Valuation

NASDAQ:AHCO • US00653Q1022

Current stock price

11.48 USD
+1.11 (+10.7%)
At close:
11.51 USD
+0.03 (+0.26%)
Pre-Market:

This AHCO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. AHCO Profitability Analysis

1.1 Basic Checks

  • AHCO had negative earnings in the past year.
  • AHCO had a positive operating cash flow in the past year.
  • In multiple years AHCO reported negative net income over the last 5 years.
  • Each year in the past 5 years AHCO had a positive operating cash flow.
AHCO Yearly Net Income VS EBIT VS OCF VS FCFAHCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

  • AHCO has a Return On Assets (-1.63%) which is in line with its industry peers.
  • AHCO has a Return On Equity of -4.63%. This is comparable to the rest of the industry: AHCO outperforms 47.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.98%, AHCO is in line with its industry, outperforming 48.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AHCO is below the industry average of 8.86%.
Industry RankSector Rank
ROA -1.63%
ROE -4.63%
ROIC 3.98%
ROA(3y)-4.95%
ROA(5y)-2.19%
ROE(3y)-15.31%
ROE(5y)-7.22%
ROIC(3y)4.65%
ROIC(5y)3.98%
AHCO Yearly ROA, ROE, ROICAHCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

1.3 Margins

  • AHCO has a better Operating Margin (6.34%) than 70.00% of its industry peers.
  • In the last couple of years the Operating Margin of AHCO has grown nicely.
  • AHCO has a Gross Margin (21.07%) which is in line with its industry peers.
  • AHCO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.34%
PM (TTM) N/A
GM 21.07%
OM growth 3Y-0.39%
OM growth 5Y3.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.81%
GM growth 5Y5%
AHCO Yearly Profit, Operating, Gross MarginsAHCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

1

2. AHCO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AHCO is destroying value.
  • Compared to 1 year ago, AHCO has more shares outstanding
  • Compared to 5 years ago, AHCO has more shares outstanding
  • The debt/assets ratio for AHCO has been reduced compared to a year ago.
AHCO Yearly Shares OutstandingAHCO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
AHCO Yearly Total Debt VS Total AssetsAHCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of 1.04, we must say that AHCO is in the distress zone and has some risk of bankruptcy.
  • AHCO has a worse Altman-Z score (1.04) than 68.00% of its industry peers.
  • The Debt to FCF ratio of AHCO is 8.14, which is on the high side as it means it would take AHCO, 8.14 years of fcf income to pay off all of its debts.
  • AHCO has a Debt to FCF ratio (8.14) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.15 is on the high side and indicates that AHCO has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.15, AHCO is doing worse than 62.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 8.14
Altman-Z 1.04
ROIC/WACC0.53
WACC7.49%
AHCO Yearly LT Debt VS Equity VS FCFAHCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.02 indicates that AHCO should not have too much problems paying its short term obligations.
  • AHCO's Current ratio of 1.02 is on the low side compared to the rest of the industry. AHCO is outperformed by 70.00% of its industry peers.
  • AHCO has a Quick Ratio of 1.02. This is a bad value and indicates that AHCO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.81, AHCO is doing worse than 76.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.81
AHCO Yearly Current Assets VS Current LiabilitesAHCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. AHCO Growth Analysis

3.1 Past

  • The earnings per share for AHCO have decreased strongly by -230.00% in the last year.
  • AHCO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.95%.
  • The Revenue has been growing by 25.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-230%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.53%
Revenue 1Y (TTM)-19.95%
Revenue growth 3Y2.99%
Revenue growth 5Y25.16%
Sales Q2Q%-1.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.39% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 6.53% on average over the next years.
EPS Next Y229.95%
EPS Next 2Y90.01%
EPS Next 3Y53.13%
EPS Next 5Y33.39%
Revenue Next Year7.34%
Revenue Next 2Y7.14%
Revenue Next 3Y6.53%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AHCO Yearly Revenue VS EstimatesAHCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
AHCO Yearly EPS VS EstimatesAHCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

6

4. AHCO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AHCO. In the last year negative earnings were reported.
  • AHCO is valuated reasonably with a Price/Forward Earnings ratio of 11.33.
  • Based on the Price/Forward Earnings ratio, AHCO is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of AHCO to the average of the S&P500 Index (22.67), we can say AHCO is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 11.33
AHCO Price Earnings VS Forward Price EarningsAHCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • AHCO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AHCO is cheaper than 93.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AHCO is valued cheaply inside the industry as 89.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.11
EV/EBITDA 5.52
AHCO Per share dataAHCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AHCO's earnings are expected to grow with 53.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.01%
EPS Next 3Y53.13%

0

5. AHCO Dividend Analysis

5.1 Amount

  • AHCO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AHCO Fundamentals: All Metrics, Ratios and Statistics

ADAPTHEALTH CORP

NASDAQ:AHCO (3/24/2026, 8:13:20 PM)

Premarket: 11.51 +0.03 (+0.26%)

11.48

+1.11 (+10.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners94.59%
Inst Owner Change0.93%
Ins Owners2.38%
Ins Owner Change6.01%
Market Cap1.56B
Revenue(TTM)3.24B
Net Income(TTM)-70.27M
Analysts81.43
Price Target13.64 (18.82%)
Short Float %6.26%
Short Ratio6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-174.1%
Min EPS beat(2)-312.88%
Max EPS beat(2)-35.31%
EPS beat(4)0
Avg EPS beat(4)-471.13%
Min EPS beat(4)-1325.49%
Max EPS beat(4)-35.31%
EPS beat(8)1
Avg EPS beat(8)-252.52%
EPS beat(12)3
Avg EPS beat(12)-252.41%
EPS beat(16)3
Avg EPS beat(16)-207.71%
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)0.61%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)0.61%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0%
PT rev (3m)0.94%
EPS NQ rev (1m)-61.77%
EPS NQ rev (3m)-70.46%
EPS NY rev (1m)-0.87%
EPS NY rev (3m)-1.73%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0.77%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.33
P/S 0.48
P/FCF 7.11
P/OCF 2.59
P/B 1.03
P/tB N/A
EV/EBITDA 5.52
EPS(TTM)-0.78
EYN/A
EPS(NY)1.01
Fwd EY8.83%
FCF(TTM)1.61
FCFY14.06%
OCF(TTM)4.43
OCFY38.57%
SpS23.88
BVpS11.17
TBVpS-8.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.63%
ROE -4.63%
ROCE 5.71%
ROIC 3.98%
ROICexc 4.1%
ROICexgc 16.44%
OM 6.34%
PM (TTM) N/A
GM 21.07%
FCFM 6.76%
ROA(3y)-4.95%
ROA(5y)-2.19%
ROE(3y)-15.31%
ROE(5y)-7.22%
ROIC(3y)4.65%
ROIC(5y)3.98%
ROICexc(3y)4.77%
ROICexc(5y)4.1%
ROICexgc(3y)18.14%
ROICexgc(5y)17.62%
ROCE(3y)6.67%
ROCE(5y)5.71%
ROICexgc growth 3Y7.72%
ROICexgc growth 5Y-6.09%
ROICexc growth 3Y13.34%
ROICexc growth 5Y5.89%
OM growth 3Y-0.39%
OM growth 5Y3.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.81%
GM growth 5Y5%
F-Score3
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 8.14
Debt/EBITDA 2.98
Cap/Depr 100.12%
Cap/Sales 11.78%
Interest Coverage 2.03
Cash Conversion 102.41%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.81
Altman-Z 1.04
F-Score3
WACC7.49%
ROIC/WACC0.53
Cap/Depr(3y)90.69%
Cap/Depr(5y)92.45%
Cap/Sales(3y)10.57%
Cap/Sales(5y)10.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-230%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.53%
EPS Next Y229.95%
EPS Next 2Y90.01%
EPS Next 3Y53.13%
EPS Next 5Y33.39%
Revenue 1Y (TTM)-19.95%
Revenue growth 3Y2.99%
Revenue growth 5Y25.16%
Sales Q2Q%-1.21%
Revenue Next Year7.34%
Revenue Next 2Y7.14%
Revenue Next 3Y6.53%
Revenue Next 5YN/A
EBIT growth 1Y-43.79%
EBIT growth 3Y2.59%
EBIT growth 5Y29.25%
EBIT Next Year175.81%
EBIT Next 3Y46.97%
EBIT Next 5YN/A
FCF growth 1Y-6.96%
FCF growth 3YN/A
FCF growth 5Y7.08%
OCF growth 1Y11.06%
OCF growth 3Y17.19%
OCF growth 5Y25.2%

ADAPTHEALTH CORP / AHCO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AHCO.


What is the valuation status of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a valuation rating of 6 / 10 to ADAPTHEALTH CORP (AHCO). This can be considered as Fairly Valued.


How profitable is ADAPTHEALTH CORP (AHCO) stock?

ADAPTHEALTH CORP (AHCO) has a profitability rating of 4 / 10.